Somnoware Healthcare Systems
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$9.0m | Series A | ||
N/A | $3.5m | Seed | |
N/A | $5.0m | Series A | |
* | N/A | Early VC | |
* | N/A | Acquisition | |
Total Funding | €15.9m |
Recent News about Somnoware Healthcare Systems
EditSomnoware, launched in 2013, is a cloud-based respiratory healthcare management platform designed to streamline the diagnosis and treatment of chronic respiratory ailments such as COPD and Obstructive Sleep Apnea (OSA). The platform significantly reduces the time to diagnosis by 80%, enhances therapy effectiveness by 30%, and can cut hospital readmissions by up to 67%. Serving 1 in 5 pulmonologists, Somnoware operates in the digital health market, focusing on improving patient outcomes and reducing healthcare costs. The company generates revenue through a Software-as-a-Service (SaaS) model, offering its platform to healthcare providers, sleep labs, and durable medical equipment (DME) companies. Somnoware's leadership team comprises experienced professionals in digital health, SaaS, and data analytics, all driven by a passion for transforming respiratory healthcare. The company is backed by leading digital health industry champions and guided by medical advisors who are thought leaders in sleep healthcare. Somnoware's mission is to manage chronic respiratory diseases effectively, thereby improving patient quality of life and reducing associated healthcare costs.
Keywords: respiratory healthcare, cloud-based platform, COPD, OSA, digital health, SaaS, pulmonologists, therapy effectiveness, hospital readmissions, healthcare costs.